BeOne Medicines
ONC
#638
Rank
C$51.16 B
Marketcap
C$462.38
Share price
-1.91%
Change (1 day)
65.03%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total assets

Total assets on the balance sheet as of September 2025 : C$10.64 Billion

According to BeOne Medicines's latest financial reports the company's total assets are C$10.64 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BeOne Medicines - Total assets on balance sheet (from 2014 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$8.49 B10.35%
2023-12-31C$7.69 B-11.05%
2022-12-31C$8.65 B-20.42%
2021-12-31C$10.87 B52.32%
2020-12-31C$7.14 B239.14%
2019-12-31C$2.10 B-31.29%
2018-12-31C$3.06 B132.92%
2017-12-31C$1.31 B141.25%
2016-12-31C$0.54 B236.69%
2015-12-31C$0.16 B160.3%
2014-12-31C$62.22 M395.47%
2013-12-31C$12.55 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Onconova Therapeutics
ONTX
C$25.35 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C$2.78 B-73.86%๐Ÿ‡บ๐Ÿ‡ธ USA